STOK Stoke Therapeutics
- 14.620
- +0.840+6.10%
- 14.600
- -0.020-0.14%
Stoke Therapeutics News
Stoke Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nash Huw M.
Stoke Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kaye Edward M. MD
Stoke Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Allan Jonathan
Stoke Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Stoke Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Stoke Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Stoke Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Leggett Thomas
Stoke Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Leggett Thomas
Stoke Therapeutics | 10-Q: Quarterly report
Stoke Therapeutics | 8-K: Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
Stoke Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ticho Barry
Stoke Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Stoke Therapeutics | 8-K: Current report
Stoke Therapeutics | ARS: Annual Report to Security Holders
Stoke Therapeutics | DEF 14A: Definitive information statements
Stoke Therapeutics | DEFA14A: Others
Stoke Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Montrago Trustees Limited(23.4%),Skorpios Trust(23.4%), etc.
Stoke Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Skorpios Trust
Stoke Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Stoke Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
